Depomed Patents Challenged By Purdue Survive AIA Review
The U.S. Patent and Trademark Office on Wednesday ruled in favor of Depomed Inc. in an inter partes review requested by Purdue Pharma LP, finding that Purdue failed to prove that...To view the full article, register now.
Already a subscriber? Click here to view full article